304 related articles for article (PubMed ID: 18987758)
1. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
Hölscher B; Heitmeyer C; Fobker M; Breithardt G; Schaefer RM; Reinecke H
Can J Cardiol; 2008 Nov; 24(11):845-50. PubMed ID: 18987758
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial.
Reinecke H; Fobker M; Wellmann J; Becke B; Fleiter J; Heitmeyer C; Breithardt G; Hense HW; Schaefer RM
Clin Res Cardiol; 2007 Mar; 96(3):130-9. PubMed ID: 17180572
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
[TBL] [Abstract][Full Text] [Related]
4. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of different laboratory measures of renal function for long-term mortality after contrast media-associated renal impairment.
Heitmeyer C; Hölscher B; Fobker M; Breithardt G; Hausberg M; Reinecke H
Clin Cardiol; 2010 Dec; 33(12):E51-9. PubMed ID: 21184545
[TBL] [Abstract][Full Text] [Related]
6. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
Vasheghani-Farahani A; Sadigh G; Kassaian SE; Khatami SM; Fotouhi A; Razavi SA; Mansournia MA; Yamini-Sharif A; Amirzadegan A; Salarifar M; Sadeghian S; Davoodi G; Borumand MA; Esfehani FA; Darabian S
Am J Kidney Dis; 2009 Oct; 54(4):610-8. PubMed ID: 19619921
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for hemodialysis and mortality in patients with contrast-induced nephropathy.
Lai HM; Aronow WS; Chugh SS; Pudasaini B; Goel A; Garrick R
Am J Ther; 2013; 20(6):607-12. PubMed ID: 22820714
[TBL] [Abstract][Full Text] [Related]
8. The Preinterventional Cystatin-Creatinine-Ratio: A Prognostic Marker for Contrast Medium-Induced Acute Kidney Injury and Long-Term All-Cause Mortality.
Lüders F; Meyborg M; Malyar N; Reinecke H
Nephron; 2015; 131(1):59-65. PubMed ID: 26287495
[TBL] [Abstract][Full Text] [Related]
9. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
Jain T; Shah S; Shah J; Jacobsen G; Khandelwal A
Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
[TBL] [Abstract][Full Text] [Related]
10. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
Garcia S; Ko B; Adabag S
Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
[TBL] [Abstract][Full Text] [Related]
11. Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions.
Li WH; Li DY; Han F; Xu TD; Zhang YB; Zhu H
Int Urol Nephrol; 2013 Aug; 45(4):1065-70. PubMed ID: 23225080
[TBL] [Abstract][Full Text] [Related]
12. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
14. Impact of female gender on frequency of contrast medium-induced nephropathy: post hoc analysis of dialysis versus diuresis trial.
Kiski D; Stepper W; Breithardt G; Reinecke H
J Womens Health (Larchmt); 2010 Jul; 19(7):1363-8. PubMed ID: 20545479
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial.
Marashizadeh A; Sanati HR; Sadeghipour P; Peighambari MM; Moosavi J; Shafe O; Firouzi A; Zahedmehr A; Maadani M; Shakerian F; Kiani R; Mohebbi B; Alemzadeh-Ansari MJ; Tahvili R; Naghavi B
Int Urol Nephrol; 2019 Oct; 51(10):1815-1822. PubMed ID: 31332700
[TBL] [Abstract][Full Text] [Related]
16. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
Chong E; Shen L; Poh KK; Tan HC
Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
[TBL] [Abstract][Full Text] [Related]
18. Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial.
Liu Y; Chen JY; Huo Y; Ge JB; Xian Y; Duan CY; Chen SQ; Jiang W; Chen PY; Tan N;
Am Heart J; 2016 Feb; 172():88-95. PubMed ID: 26856220
[TBL] [Abstract][Full Text] [Related]
19. Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.
Watanabe M; Saito Y; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
J Cardiol; 2016 Nov; 68(5):412-418. PubMed ID: 26708123
[TBL] [Abstract][Full Text] [Related]
20. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial.
Kiski D; Stepper W; Brand E; Breithardt G; Reinecke H
Nephrol Dial Transplant; 2010 Mar; 25(3):759-64. PubMed ID: 19903660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]